Sitemap

Medical science

10/2006 Leukocytosis might precede in-hospital eclampsia in preeclamptic women who do not receive magnesium sulfate
10/2006 Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy
10/2006 Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies
10/2006 Fetal behavior analyzed by ultrasonic actocardiogram in cases with central nervous system lesions
10/2006 Early weight gain does not decrease the incidence of low birth weight and small for gestational age triplets in mothers with normal pre-gestational body mass index
10/2006 Umbilical artery pulsatility index: reliability at different sampling sites
10/2006 Inferior vena cava diameter pulse waveforms in the human fetus: relationship with flow velocity waveform
10/2006 A trial of preventing early- and late-onset Group B streptococcal sepsis with combined intrapartum chemoprophylaxis and universal neonatal screening
10/2006 Impact of prenatal urinomas in patients with posterior urethral valves and postnatal renal function
10/2006 Laboratory medicine in the 2000s: programmed death or rebirth?
10/2006 Akkreditierung von POCT nach ISO 22870 – Anforderungen an Qualität und Kompetenz / Accreditation of POCT according to ISO 22870 – Requirements for quality and competence
10/2006 Hepatorenal syndrome
10/2006 Labordiagnostik von Kollagenosen unter besonderer Berücksichtigung neurologischer Manifestationen / Labaratory diagnosis of connective tissue diseases with a focus on neurological manifestations
10/2006 Labormethoden in der Schlafmedizin / The role of laboratory diagnostics in sleep medicine
10/2006 Methoden zur Bestimmung von Thrombininhibitoren / Methods for the determination of thrombin inhibitors
10/2006 Aspirin-Resistenz / Aspirin resistance
10/2006 Clopidogrel resistance
10/2006 Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening testing
11/2006 Monitoring unfractionated heparin with the aPTT: Time for a fresh look
11/2006 Thrombin generation, a function test of the haemostatic-thrombotic system
11/2006 Use of calibrated automated thrombinography thrombomodulin to recognise the prothrombotic phenotype
11/2006 Review: Laboratory markers quantifying prothrombin activation and actions of thrombin in venous and arterial thrombosis do not accurately assess disease severity or the effectiveness of treatment
11/2006 Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy
11/2006 Performance goals for the laboratory testing of antithrombin, protein C and protein S
11/2006 Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors
11/2006 The UK National External Quality Assessment Scheme (UK NEQAS) for molecular genetic testing in haemophilia
11/2006 Rat models of myocardial infarction. Pathogenetic insights and clinical relevance
11/2006 Management of cutaneous type IV hypersensitivity reactions induced by heparin
11/2006 Immunohistochemistry of thrombi following iliac venous stenting: A novel model of venous thrombosis
11/2006 The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects
11/2006 An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease
11/2006 Integrin binding characteristics of the disintegrin-like domain of ADAM-15
11/2006 Platelet-induced growth of human fibroblasts is associated with an increased expression of 5-lipoxygenase
11/2006 No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
11/2006 Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis
11/2006 Rational humanization of the powerful antithrombotic anti-GPIba antibody: 6B4
11/2006 Villonodular synovitis in the dog
11/2006 Fibrotic contracture of the canine infraspinatus muscle
11/2006 Renal function – estimation of glomerular filtration rate
11/2006 Research translation: a new frontier for clinical laboratories
11/2006 Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population
11/2006 MTRR 66A>G polymorphism in relation to congenital heart defects
11/2006 Increased homocysteine in heart failure: a result of renal impairment?
11/2006 Urine flow cytometry and detection of glomerular hematuria
11/2006 Chymotrypsin effects on the determination of sperm parameters and seminal biochemistry markers
11/2006 Evaluation of cardiac involvement following major orthopedic surgery
11/2006 Increased sensitivity in detecting renal impairments by quantitative measurement of marker protein excretion compared to detection of pathological particles in urine sediment analysis
11/2006 Clinical chemistry reference values for 75-year-old apparently healthy persons
11/2006 Serum pro-hepcidin concentrations and their responses to oral iron supplementation in healthy subjects manifest considerable inter-individual variation
11/2006 Comparability of five analytical systems for the determination of triiodothyronine, thyroxine and thyroid-stimulating hormone
11/2006 Automated analysis of pleural fluid total and differential leukocyte counts with the Sysmex XE-2100
11/2006 Automation and validation of a fast method for the assessment of in vivo oxidative stress levels
11/2006 Analytical validation of the new plasma calibrated Accu-Chek^® Test Strips (Roche Diagnostics)
11/2006 Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment
11/2006 Analytical and clinical evaluation of a new heart-type fatty acid-binding protein automated assay
12/2006 Prevention of distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction. A review of current status
12/2006 Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease
12/2006 Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease
12/2006 SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occuring before age 40
12/2006 Tiplaxtinin impairs nutritionally induced obesity in mice
12/2006 Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease
12/2006 Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden
12/2006 A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients
12/2006 Palmitoylation at Cys 595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection
12/2006 Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y 12 receptor
12/2006 Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba
12/2006 Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood
12/2006 Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells
12/2006 Focal arterial inflammation is augmented in mice with a deficiency of the protein C gene
12/2006 A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury
Back

Sitemap

Area of Science